Search Results | Cancer Research | American Association for Cancer Research

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Optimizing chemotherapeutic dose-schedule (CDS) by Norton-Simon Modeling: Capecitabine (Xeloda®= X)

Larry Norton, Ute Dugan, David Young, Colm Farrell, Yutaka Tanaka, Maria Theodoulou, Tiffany Traina, Clifford Hudis

Cancer Res (2005) 65 (9_Supplement): 1182.

Published: 01 May 2005

View article

Journal Articles

Optimal dosing schedule of capecitabine administration in human mammary tumor xenograft models.

Mieko Yanagisawa, Kaori F-Ouchi, Yutaka Tanaka

Cancer Res (2004) 64 (7_Supplement): 714.

Published: 01 April 2004

View article

Journal Articles

The Antiproliferative Activity of DMDC Is Modulated by Inhibition of Cytidine Deaminase

Hiroyuki Eda, Masako Ura, Kaori F.-Ouchi, Yutaka Tanaka, Masanori Miwa, Hideo Ishitsuka

Cancer Res (1998) 58 (6): 1165–1169.

Published: 01 March 1998

View article

Journal Articles

Molecular Analysis of the Cytokine Network Involved in Cachexia in Colon 26 Adenocarcinoma-bearing Mice

Kazuo Yasumoto, Naofumi Mukaida, Akihisa Harada, Kouji Kuno, Mariko Akiyama, Emiko Nakashima, Nakaba Fujioka, Masayoshi Mai, Tadashi Kasahara, Karoi Fujimoto-Ouchi, Kazushige Mori, Yutaka Tanaka, Kouji Matsushima

Cancer Res (1995) 55 (4): 921–927.

Published: 01 February 1995

View article

Journal Articles

Anticachectic Activity of 5′-Deoxy-5-fluorouridine in a Murine Tumor Cachexia Model, Colon 26 Adenocarcinoma

Yutaka Tanaka, Hiroyuki Eda, Kaori Fujimoto, Takashi Tanaka, Tohru Ishikawa, Hideo Ishitsuka

Cancer Res (1990) 50 (15): 4528–4532.

Published: 01 August 1990

View article

Journal Articles

Experimental Cancer Cachexia Induced by Transplantable Colon 26 Adenocarcinoma in Mice

Yutaka Tanaka, Hiroyuki Eda, Takashi Tanaka, Toshiaki Udagawa, Tohru Ishikawa, Ikuo Horii, Hideo Ishitsuka, Tateshi Kataoka, Tetsuo Taguchi

Cancer Res (1990) 50 (8): 2290–2295.

Published: 01 April 1990

View article

Journal Articles

Antitumor Activity of Indomethacin in Mice Bearing Advanced Colon 26 Carcinoma Compared with Those with Early Transplants

Yutaka Tanaka, Takashi Tanaka, Hideo Ishitsuka

Cancer Res (1989) 49 (21): 5935–5939.

Published: 01 November 1989

View article

Journal Articles

Mosaicism in the Expression of Tumor-associated Carbohydrate Antigens in Human Colonic and Gastric Cancers

Hisao Nakasaki, Toshio Mitomi, Takashi Noto, Kyoji Ogoshi, Hitoshi Hanaue, Yutaka Tanaka, Hiroyasu Makuuchi, Henrik Clausen, Sen-itiroh Hakomori

Cancer Res (1989) 49 (13): 3662–3669.

Published: 01 July 1989

View article

NARROW

Optimizing chemotherapeutic dose-schedule (CDS) by Norton-Simon Modeling: Capecitabine (Xeloda®= X)

Optimal dosing schedule of capecitabine administration in human mammary tumor xenograft models.

The Antiproliferative Activity of DMDC Is Modulated by Inhibition of Cytidine Deaminase

Molecular Analysis of the Cytokine Network Involved in Cachexia in Colon 26 Adenocarcinoma-bearing Mice

Anticachectic Activity of 5′-Deoxy-5-fluorouridine in a Murine Tumor Cachexia Model, Colon 26 Adenocarcinoma

Experimental Cancer Cachexia Induced by Transplantable Colon 26 Adenocarcinoma in Mice

Antitumor Activity of Indomethacin in Mice Bearing Advanced Colon 26 Carcinoma Compared with Those with Early Transplants

Mosaicism in the Expression of Tumor-associated Carbohydrate Antigens in Human Colonic and Gastric Cancers

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only